Key Takeaways
Enlivex Therapeutics is set to deploy $212 million from a private placement to adopt a RAIN-based digital asset treasury strategy.
The company has appointed ex-Italian PM Matteo Renzi to its Board.
Share this article
RAIN, the token associated with the Arbitrum-based prediction market platform Rain, doubled its value after Nasdaq-listed biotech firm Enlivex announced a $212 million private placement to initiate the world’s first treasury strategy centered on the token.
CoinGecko data shows that the RAIN token rose from $0.0038 to $0.0076 briefly after the announcement. As of press time, RAIN was trading at $0.007, up nearly 100% over the last 24 hours.
Enlivex will become the first public company to integrate a decentralized prediction market token into its corporate reserves. The team stated they will continue their clinical development of Allocetra, a therapy targeting osteoarthritis.
The Rain protocol enables users to create, trade, and resolve event prediction markets using a combination of DeFi mechanisms and AI-assisted dispute resolution to ensure fairness and accuracy. It is designed to be permissionless, transparent, and governed by RAIN token holders through a decentralized autonomous organization (DAO).
Alongside the treasury plan, Enlivex said that former Italian Prime Minister Matteo Renzi will join its board of directors. The funds from the placement will support the implementation of this strategy while continuing the company’s development of therapies like Allocetra for osteoarthritis.
Enlivex Chairman Shai Novik noted that growing institutional investments in prediction markets, including Polymarket and Kalshi, signal a maturing sector. He indicated that Enlivex’s RAIN treasury initiative could make it the first US-traded public company to provide access to this emerging sector.
The transaction is expected to be completed on or before November 25, 2025, subject to customary closing conditions.
